Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-120-4 | CAS number: 12070-08-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vivo
Description of key information
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- no data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- In this publication the induction of chromosomal aberration and micronuclei in bone marrow cells of mice by 65 chemicals, among them TiO2, was elucidated.
- GLP compliance:
- no
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no data
- Route of administration:
- intraperitoneal
- Vehicle:
- corn oil
- Details on exposure:
- The three exposure mouse bone marrow micronucleus test protocol is presented by Shelby et al. 1993.
TiO2 was tested for induction of micronuclei in mouse bone marrow cells using two different sacrifice times.
Groups of 5 male B6C3F1 mice were injected intraperitoneally three times at 24 h intervals with the test substance dissolved in corn oil. The total dosing volume per mouse was 0.4 ml. - Duration of treatment / exposure:
- 24 h
- Frequency of treatment:
- Three times at 24 h intervals
- Post exposure period:
- 24 h
- Remarks:
- Doses / Concentrations:
0 mg/kg
Basis:
nominal conc. - Remarks:
- Doses / Concentrations:
250 mg/kg
Basis:
nominal conc. - Remarks:
- Doses / Concentrations:
500 mg/kg
Basis:
nominal conc. - Remarks:
- Doses / Concentrations:
1000 mg/kg
Basis:
nominal conc. - Remarks:
- Doses / Concentrations:
1500 mg/kg
Basis:
nominal conc. - No. of animals per sex per dose:
- 8 animals per dose group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- It is reported that concurrent positive control groups were run for each test but the data are not presented.
- Tissues and cell types examined:
- 24 h after the final injection smears of the bone marrow cells from femurs were prepared.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: not specified; based on a preliminary dose range study and another publication by Shelby et al. 1993.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): 24 h after the final injection smears of the bone marrow cells from femurs were prepared.
DETAILS OF SLIDE PREPARATION: Air-dried smears were fixed and stained with acridine orange;
METHOD OF ANALYSIS: 2000 polychromatic erythrocytes PCE were scored per animal for frequency of micronucleated cells. The percentage of the PCEs among the total erythrocyte population in the bone marrow was scored for each dose group as a measure of toxicity. The results were tabulated as the mean of the pooled results from all animals within a treatment group, plus or minus the standard error mean. - Statistics:
- Data were analysed using the Micronucleus Assay Data Management and Statistical software package (version 1.4) that employed a one-tailed Cochran-Armitage trend test across exposure groups and pairwise comparison between exposure group and concurrent control. The level of significance was set at an alpha level of 0.05.
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- other: not reported
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY:
a preliminary dose-determination experiment was carried out. Details on the preliminary test are not reported
RESULTS OF DEFINITIVE STUDY
- Types of structural aberrations for significant dose levels (for Cytogenetic or SCE assay): the test substance did not induice structural aberrations
- Induction of micronuclei (for Micronucleus assay): yes; see Table 1
- Ratio of PCE/NCE (for Micronucleus assay): not reported
- Appropriateness of dose levels and route: no data
- Statistical evaluation: Data were analysed using the Micronucleus Assay Data Management and Statistical software package (version 1.4) that employed a one-tailed Cochran-Armitage trend test across exposure groups and pairwise comparison between exposure group and concurrent control. The level of significance was set at an alpha level of 0.05. - Conclusions:
- Interpretation of results (migrated information): negative
Under the reported experimental conditions TiO2 did not induce significant elevated levels of micronuclei in the bone marrow cells of the mouse. Therefore TiO2, is considered to be non-mutagenic in this micronucleus assay. - Executive summary:
In a B6C3F1 mouse bone marrow micronucleus test, 5 male mice per dose were treated intraperitoneally with Titanium dioxide at doses of 0, 250, 500, 1000 and 1500 mg/kg bw. The animals were injected intraperitoneally three times at 24 h intervals. The vehicle was corn oil.
The initial micronucleus test gave a significant trend with the effect at the highest dose significantly elevated; the effects observed were small. In a second trial, effects of a similar magnitude were observed. However this result was only seen in a single dose, was not concentration dependent and only of minor significance. Therefore this effect is judged as irrelevant biological fluctuation.
Therefore, Titanium Dioxide is not considered to be mutagenic according to the results of the in vivo micronucleus test reported here.
Reference
The MN data on TiO2 described here were originally published by Shelby
et al. (1993).
The initial MN experiment on TiO2 (0, 250, 500, 1000 mg/kg bw) gave a
significant trend with the effect at the highest dose (1000 mg/kg bw)
significantly elevated; however, the effects observed were small.
In a second trial on TiO2 (0, 500, 1000, 1500 mg/kg bw) , a single dose
group (1000 mg/kg bw) was significantly elevated. However this result
was only seen in a single dose, was not concentration dependent and only
of minor significance. Therefore this effect is judged as irrelevant
biological fluctuation.
Table1: TiO2 Micronucleus Test (solvent corn oil; bone marrow cells)
Dose (mg/kg bw) |
MN-PCE/1,000 |
Trend P value |
Survival (No. scored) |
1sttrial |
|||
0 |
1.7±0.26 |
0.016* |
(5/5) |
250 |
3.00± 0.47 |
(5/5) |
|
500 |
2.60± 0.49 |
(5/5) |
|
1000 |
3.50± 0.45* |
(5/5) |
|
2ndtrial |
|||
0 |
1.50± 0.27 |
0.128 (0.002)c,* |
(5/5) |
500 |
2.60± 0.37 |
(5/5) |
|
1000 |
3.60± 0.78* |
(5/5) |
|
1500 |
2.00± 0.35 |
(5/5) |
* Significant positive effect
c Trend test P value after dropping high dose group
Furthermore the chromosome aberration test also reported in the same reference, no clastogenic effects could be observed at all doses (0, 625, 1250, 2500 mg/kg bw). Thus it can be concluded that TiO2 has no clastogenic effect in vivo.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In vitro genetic toxicity tests:
Titanium dioxide did not induce effects in most of the reported in vitro genotoxicity assays (bacterial mutagenicity (Zeiger, 1988, Kanematsu, 1984; mouse lymphoma assay (Myhr, 1991), micronucleus assay (Miller, 1995); Sister Chromatide Exchange & Chromosome aberration assay (Invett, 1989)). Contradicting results have been reported in CHO cells by Lu (1998) (positive Sister Chromatide & micronucleus assay). Positive results have also been reported by Türkez (2007) in human erythrocytes (Sister Chromatide Exchange & micronucleus assay). However, in the latter report the activities of antioxidant enzymes in erythrocytes showed significant decreases with increasing doses of TiO2. Thus, it seems to be a secondary genotoxic effect caused by an increase in reactive oxygen species.
In vivo genetic toxicity tests:
Titanium dioxide does not induce micronuclei or chromosome aberration in the bone marrow of male B6C3F1 mice following a single intraperitoneal injection of 1500 and 2500 mg titanium dioxide /kg bw, respectively (Shelby, 1995). In addition TiO2 is negative in a Drosophila sex-linked recessive lethal (SLRL) assay (Foureman, 1994).
From the available data it can be concluded, that titanium dioxide is not genotoxic. These data are used for read-across to Titanium carbide.
Justification for selection of genetic toxicity endpoint
valid in vivo micro nucleus test
Justification for classification or non-classification
The majority of in vitro genotoxicity studies, among them a bacterial reverse mutation assays, mammalian cell gene mutation tests (TK assay) and mammalian cell chromosome aberration are negative, supporting the negative findings in three in vivo tests as cited above. Therefore, Titanium dioxide is not considered to be mutagenic. These data are used for read-across to Titanium carbide.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.